1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc
XNAS: KROS

Keros Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

Read More
10.99 -1.00 (-8.34%)
New 52W Low today
725.4K
XNAS Volume
High volume+loss today

XNAS 14 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Affordable Valuation
74.2 / 100
Momentum Score
Technically Neutral
36.3 / 100
Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM
Analyst Price Target
22
1Yr Price target upside is 99%
6 analysts

7

S

13

W

4

O

1

T

SWOT Analysis

Keros Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
×